SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-24-027110
Filing Date
2024-08-16
Accepted
2024-08-16 17:25:03
Documents
103

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A pbla20240815_s1a.htm   iXBRL S-1/A 2478287
2 EXHIBIT 23.1 ex_715580.htm EX-23.1 2550
3 EXHIBIT FILING FEES ex_715581.htm EX-FILING FEES 40436
9 figure1.jpg GRAPHIC 38452
10 figure2.jpg GRAPHIC 26461
11 figure3.jpg GRAPHIC 21511
12 logo01.jpg GRAPHIC 9008
  Complete submission text file 0001437749-24-027110.txt   10032600

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240630.xsd EX-101.SCH 80143
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240630_def.xml EX-101.DEF 625581
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240630_lab.xml EX-101.LAB 376230
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240630_pre.xml EX-101.PRE 662635
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20240630_cal.xml EX-101.CAL 65413
107 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240815_s1a_htm.xml XML 1139699
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278798 | Film No.: 241217666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)